Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883801691> ?p ?o ?g. }
- W2883801691 abstract "Cisplatin, as a first‑line chemotherapy drug, has been widely applied for therapy of osteosarcoma. However, its application is limited by drug resistance and serious side effects, including nephrotoxicity and ototoxicity. Suberoylanilide hydroxamic acid (SAHA) is a newly developed histone deacetylase (HDAC) inhibitor, which is the first Food and Drug Administration‑approved HDAC inhibitor for the treatment of cutaneous manifestations of T‑cell lymphoma. However, SAHA as a monotherapy was revealed to be limited, particularly in solid tumors. In the present study, 143B osteosarcoma cells were treated with multiple concentrations of SAHA or cisplatin, either alone or combined. The morphological characteristics of the treated cells were observed using an inverted microscope. The cytotoxicity effects of the combination of SAHA and cisplatin on 143B cells were analyzed by MTT assay, colony formation assay, wound healing cell migration assay, cell apoptosis assay and cell cycle analysis. Western blot analysis was performed to detect the protein expression levels of B cell lymphoma‑2 (Bcl‑2)‑associated X protein (Bax), Bcl‑2, cleaved‑caspase‑3, cleaved‑caspase‑8 and cleaved‑poly (ADP‑ribose) polymerase (PARP). The experimental data indicated that the inhibition of cell proliferation in the combination group was significantly increased compared with that in single drug groups. Expression levels of pro‑apoptotic protein were upregulated, whereas anti‑apoptotic Bcl‑2 was downregulated significantly in 143B cells following SAHA/cisplatin treatment. Taken together, the results revealed that the combination of SAHA and cisplatin inhibited the proliferation of 143B cells and induced their apoptosis synergistically, and this effectiveness may be mediated by caspase activation." @default.
- W2883801691 created "2018-08-03" @default.
- W2883801691 creator A5008400364 @default.
- W2883801691 creator A5027335182 @default.
- W2883801691 creator A5028387689 @default.
- W2883801691 creator A5036845414 @default.
- W2883801691 creator A5047355088 @default.
- W2883801691 creator A5053672435 @default.
- W2883801691 creator A5063138741 @default.
- W2883801691 creator A5077034272 @default.
- W2883801691 date "2018-07-27" @default.
- W2883801691 modified "2023-09-27" @default.
- W2883801691 title "Synergistic antitumor effect of suberoylanilide hydroxamic acid and cisplatin in osteosarcoma cells" @default.
- W2883801691 cites W1487070667 @default.
- W2883801691 cites W1543827436 @default.
- W2883801691 cites W1812576394 @default.
- W2883801691 cites W1968568016 @default.
- W2883801691 cites W1974831163 @default.
- W2883801691 cites W1976298557 @default.
- W2883801691 cites W1977454730 @default.
- W2883801691 cites W1985389100 @default.
- W2883801691 cites W1987604182 @default.
- W2883801691 cites W1989487705 @default.
- W2883801691 cites W1990642743 @default.
- W2883801691 cites W1997066354 @default.
- W2883801691 cites W2000759232 @default.
- W2883801691 cites W2006866162 @default.
- W2883801691 cites W2013177151 @default.
- W2883801691 cites W2013439755 @default.
- W2883801691 cites W2020920713 @default.
- W2883801691 cites W2049521368 @default.
- W2883801691 cites W2061910833 @default.
- W2883801691 cites W2083264756 @default.
- W2883801691 cites W2083573017 @default.
- W2883801691 cites W2086384126 @default.
- W2883801691 cites W2093282189 @default.
- W2883801691 cites W2098002569 @default.
- W2883801691 cites W2104600818 @default.
- W2883801691 cites W2131695680 @default.
- W2883801691 cites W2136399690 @default.
- W2883801691 cites W2146399575 @default.
- W2883801691 cites W2147140408 @default.
- W2883801691 cites W2150482306 @default.
- W2883801691 cites W2164277862 @default.
- W2883801691 cites W2164614740 @default.
- W2883801691 cites W2169652051 @default.
- W2883801691 cites W2171006164 @default.
- W2883801691 cites W2197271423 @default.
- W2883801691 cites W2238190328 @default.
- W2883801691 cites W2259656061 @default.
- W2883801691 cites W2276369407 @default.
- W2883801691 cites W2284980807 @default.
- W2883801691 cites W2325707043 @default.
- W2883801691 cites W2591354127 @default.
- W2883801691 cites W2600452401 @default.
- W2883801691 cites W2620241325 @default.
- W2883801691 doi "https://doi.org/10.3892/ol.2018.9224" @default.
- W2883801691 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6126343" @default.
- W2883801691 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30197679" @default.
- W2883801691 hasPublicationYear "2018" @default.
- W2883801691 type Work @default.
- W2883801691 sameAs 2883801691 @default.
- W2883801691 citedByCount "4" @default.
- W2883801691 countsByYear W28838016912019 @default.
- W2883801691 countsByYear W28838016912021 @default.
- W2883801691 crossrefType "journal-article" @default.
- W2883801691 hasAuthorship W2883801691A5008400364 @default.
- W2883801691 hasAuthorship W2883801691A5027335182 @default.
- W2883801691 hasAuthorship W2883801691A5028387689 @default.
- W2883801691 hasAuthorship W2883801691A5036845414 @default.
- W2883801691 hasAuthorship W2883801691A5047355088 @default.
- W2883801691 hasAuthorship W2883801691A5053672435 @default.
- W2883801691 hasAuthorship W2883801691A5063138741 @default.
- W2883801691 hasAuthorship W2883801691A5077034272 @default.
- W2883801691 hasBestOaLocation W28838016911 @default.
- W2883801691 hasConcept C104317684 @default.
- W2883801691 hasConcept C126322002 @default.
- W2883801691 hasConcept C153911025 @default.
- W2883801691 hasConcept C185592680 @default.
- W2883801691 hasConcept C190283241 @default.
- W2883801691 hasConcept C2776202225 @default.
- W2883801691 hasConcept C2776694085 @default.
- W2883801691 hasConcept C2778239845 @default.
- W2883801691 hasConcept C2778305200 @default.
- W2883801691 hasConcept C2780783641 @default.
- W2883801691 hasConcept C29537977 @default.
- W2883801691 hasConcept C502942594 @default.
- W2883801691 hasConcept C55493867 @default.
- W2883801691 hasConcept C62112901 @default.
- W2883801691 hasConcept C64927066 @default.
- W2883801691 hasConcept C71924100 @default.
- W2883801691 hasConcept C86803240 @default.
- W2883801691 hasConcept C98274493 @default.
- W2883801691 hasConceptScore W2883801691C104317684 @default.
- W2883801691 hasConceptScore W2883801691C126322002 @default.
- W2883801691 hasConceptScore W2883801691C153911025 @default.
- W2883801691 hasConceptScore W2883801691C185592680 @default.
- W2883801691 hasConceptScore W2883801691C190283241 @default.
- W2883801691 hasConceptScore W2883801691C2776202225 @default.
- W2883801691 hasConceptScore W2883801691C2776694085 @default.